Related Experiment Video
Updated: Aug 16, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
Total parenteral nutrition-related cholestasis in infants
Insights
Total parenteral nutrition (TPN) is associated with cholestasis in infants. Risk factors include intracranial hemorrhage, patent ductus arteriosus, sepsis, and surgical gastrointestinal conditions, influencing TPN-related cholestasis development.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Epidemiology
Background:
- Infants requiring total parenteral nutrition (TPN) are at risk for cholestasis.
- Understanding risk factors for TPN-related cholestasis is crucial for infant health management.
Purpose of the Study:
- To estimate the incidence of TPN-associated cholestasis in neonates.
- To identify specific risk factors contributing to TPN-related cholestasis in infants.
Main Methods:
- Epidemiological study design utilizing retrospective data.
- Analysis of medical records from 624 infants aged ≤30 days receiving TPN.
- Definition of TPN-related cholestasis: direct bilirubin ≥1.5 mg/dl post-TPN initiation.
- Multiple logistic regression for risk factor assessment.
Main Results:
- The incidence of TPN-related cholestasis was 7.4% (46 out of 624 infants).
- Significant risk factors identified: intracranial hemorrhage, patent ductus arteriosus, sepsis, and surgical gastrointestinal conditions.
- Hypoxia-associated conditions (PDA, ICH) and TPN may trigger cholestasis; sepsis/GI surgery may cause cholestasis independently.
Conclusions:
- TPN-related cholestasis affects a notable proportion of infants.
- Specific comorbidities significantly increase the risk of cholestasis in infants receiving TPN.
- Distinct pathophysiological pathways may underlie cholestasis development in TPN-dependent infants based on underlying conditions.
Abstract:
An epidemiological study was conducted to estimate the proportion of infants on total parenteral nutrition (TPN) who developed cholestasis and to identify risk factors associated with the development of this disease. Data were abstracted from medical records of 624 infants less than or equal to 30 days of age who were treated with TPN. A case of TPN-related cholestasis was defined as an infant whose serum level of direct bilirubin was greater than or equal to 1.5 mg/dl subsequent to initiation of TPN. Risk factors were assessed using multiple logistic regression analysis. Forty-six of 624 infants in the cohort (7.4%) were classified as having TPN-related cholestasis. The multivariable analysis indicated that cholestasis was associated with intracranial hemorrhage, patent ductus arteriosus, sepsis and gastrointestinal conditions that require surgery. Two distinct processes appear to have occurred: in infants who experienced patent ductus arteriosus or intracranial hemorrhage (conditions associated with hypoxia) where TPN may be the necessary trigger for the development of cholestasis, and in infants with gastrointestinal conditions requiring surgery or sepsis, where cholestasis may develop with or without parenteral infusions.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Cholecystitis
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology

